Allergan (AGN) Advises Shareholders to Ignore Pershing Square

Allergan Inc (AGN) on Friday advised stockholders not to act on a proposal by investment firm Pershing Square Capital Management LP to replace a majority of the Botox maker’s board. Bill Ackman’s Pershing Square, who together with Valeant Pharmaceuticals I’ntl Inc (VRX) have launched a hostile takeover offer for the California-based company, has named six […] View the full post at: Allergan (AGN) Advises Shareholders to Ignore Pershing Square Related posts: Microsoft, Hewlett-Packard Increase Stock Buybacks CIT Group Obtains $4.5B in Financing Walt Disney to Acquire Marvel Entertainment for $4B